Abstract: Plants are fantastic sources for present day life saving drugs. Monocrotaline a natural ligand exhibits dose-dependent cytotoxicity with potent antineoplastic activity. This study was intended to disclose the therapeutic potential of monocrotaline against hepatocellular carcinoma. The in silico predictions have highlighted the antineoplastic potential, druglikeness and biodegradability of monocrotaline. The in silico docking study has provided an insight and evidence for the antineoplastic activity of monocrotaline against p53, HGF and TREM1 proteins which play a threatening role in causing hepatocellular carcinoma. The mode of action of monocrotaline was determined experimentally by in vitro techniques such as XTT assay, NRU assay and whole cell brine shrimp assay have further supported our in silico studies. The in vitro cytotoxicity of monocrotaline was proved at IC50 24.966 µg/mL and genotoxicity at 2 X IC50 against HepG2 cells. Further, the credible druglike properties with non-mutagenicity, non-toxic on mammalian fibroblast and the potential antineoplastic activity through in vitro experimental validations established monocrotaline as a novel scaffold for liver cancer with superior efficacy and lesser side effects.
INTRODUCTION
Cancer is an unregulated growth of cells and the most traumatic disease in the world with 10 million new cases every year. Liver cancer is causing most of the cancer deaths in the world after lung and stomach cancers [1] . The hepatic cells of the liver become chronic due to liver diseases and infections, cause cirrhosis of liver and subsequently lead to liver cancer. Liver cancer is known as Hepatocellular Carcinoma (HCC) in MeSH (Medical Subject Headings). Every year 600,000 people die of chronic consequences of the liver in Asia and Africa. The increased risk of liver cancer incidences around the world are mainly due to factors like usage of tobacco products, alcohol consumption, physical inactivity, unhealthy diet habits, high body mass index, urban air pollution and low intake of vegetable and fruits [2] . The root cause of liver disorder is due to major factors like genetic disorders and infections caused by virus like Hepatitis C virus, Hepatitis B Virus [3] . The mutations in genes are also responsible for HCC resulting in abnormalities in cellular and nuclear morphology that affects the signal transduction pathways. This thereby induces apoptosis in cells, causing mutations leading, to the delayed arrest of cell-cycle without DNA repair [4, 5] . HCC occurs irrespective of gender [6] . HCC is aggressively fatal due to its poor prognosis and does not become symptomatic until advanced stages [7, 8] .
Over the heterogeneous population of molecular targets for HCC, factors like p53, Hepatocyte Growth Factor (HGF) and Triggering Receptor Expressed on Myeloid Cell-1 (TREM1) are majorly involved in causing HCC. The DNA damage in the liver cells influences p53 gene, resulting in mutations affecting the core domain of p53 tumor suppressor protein causing liver cancer. Such mutations in the p53 tumor suppressor genes are most recurrently practical in human liver cancer [9, 10] . The HGF is another essential factor involved in normal development of liver tissues. However, any abnormalities in HGF results in abnormal growth of tissues and development of many solid tumors [11] . HGF is believed to play an major role in metastasis and tumor migration of liver tumors and aids in tumor progression in humans [12, 13] . The TREM1 is a pro-inflammatory myeloid cell surface receptor in humans involved in causing HCC. The kupffer cells of liver regulate the inflammatory processes and promote liver cancer by expressing TREM1. The TREM-1 is involved in liver carcinogenesis due to chronic inflammation, which slowly develops into tumors that gradually metastasizes [14] . The inhibition of the TREM-1 signaling pathway can possibly be a rational target for clinical situations to manage human HCC [15] . In vitro studies using cell lines are proven to have considerable potential for assessing anti-proliferative activity of natural products. HepG2 cell line contains human HCC cells and is a suitable in vitro model system for studying liver diseases, liver metabolism, the hepatotoxicity of drugs and other toxicology studies [16] . HepG2 cell line showed expression of p53 by Western blotting [17] . HGF has an oncogenic potential in the generation of HCC observed from the molecular details of HepG2 cell line [14] . However, meager reports are available for TREM1 protein, which plays a crucial role in HCC. This mechanistic understanding of p53, HGF and TREM1 factors has helped to prefer these factors as drug-targets for the study.
Many significant therapies are being tested in the course of treating HCC, but effective chemotherapies are not reported due to low responses to present chemotherapeutics. The urge to discover effective strategies for treatment of HCC using medicinal plants is of great interest. Hence, it is better to search for proved activities rather than selecting a plant randomly [18] . In Fabaceae family, Crotalaria species synthesize a pyrrolizidine alkaloid (PA) called Monocrotaline (MCT) with potent medicinal values [19] . The seeds of Crotalaria retusa Linn contain high amount of MCT with traces of toxicity [20] . However, development of resistance pattern against toxicity is also observed at lower concentrations [20, 21] . MCT is a potent anti-cancer, immune stimulant, cardio-depressant, hypotensive and cytotoxic agent [22, 23, 24] . MCT is metabolized and detoxified by Glutathione S-transferase, epoxide hydrolase enzymes in liver [25] . In humans, detoxification of PA is catalyzed by CYP3A4 [26] . So, the present study was undertaken to assess the antineoplastic activity of MCT against HCC using in silico and in vitro approaches.
MATERIALS AND METHODS

In Silico Predictive Studies of MCT
In vitro techniques give a high degree of accuracy, but it is exciting to observe the in vitro results through in silico techniques. Significant accuracy in predicting the human hazards is achieved by the quality of expert systems.
In Silico Predictive Druglikeness of MCT
The QSAR models are developed for assessing various ADME properties, toxic endpoints of similar compounds, mutagenicity and carcinogenicity of the compounds [27, 28] . The 3D coordinates of MCT are retrieved from Pubchem for further in silico analysis. The 3D structure of MCT was subjected to QikProp for predicting the ADME properties [29] . Toxicological risks of MCT like mutagenicity, carcinogenicity are predicted using LAZAR tool [30] .
Metabolism and Degradation Pathway of MCT
The most liable sites of metabolism of MCT mediated by cytochrome P450 (CYP) isoforms are predicted using SMARTCyp v2.4.2 online tool. This tool predicts the site of metabolism (SOM) of drug-like compounds and assigns ranking to the sites of metabolism based on score (S), energy (E), accessibility (A) and solvent accessible surface area (SASA) [31] . The lowest rank is assigned lowest score, which is the best probability of being the site of metabolism with an accuracy of 82.3% and accuracy for other CYP isoforms 1A2, 2A6, 2B6, 2D6, 2C8, 2C9, 2C19 and 2E1 merged is 86.0% [32] .
The microbial biotransformation pathway of drug-like compounds to assess the chemical risks rapidly can be estimated by using UM-BBD Pathway Prediction System (PPS) [33] . The microbial degradation pathway of MCT was generated through a rule-based substrate searching and atom-to-atom mapping using PPS in order to identify organic functional groups of MCT. The PPS also helps in prediction of biotransformation rules (bt) of MCT and to analyze biological degradation through aerobic likelihood.
Biological Activity Spectra Prediction of MCT
The potent biological activities of MCT are revealed using PASS Online (Prediction of Activity Spectra for Substances). PASS predicts biological activities, related pharmacological effects, mechanisms of action from the available databases of 250,000 compounds, based on the structural formula of the substances [34] . PASS predictions provide existing chemical descriptors and completely new descriptors of the compounds and estimates the probability to be active (Pa) or inactive (Pi). If Pa > 0.7 then the compound is very likely to exhibit the estimated activity in the experiment and if it is between 0.5 < Pa < 0.7 then the compound is likely to show the activity in an experiment but the probability is less. However, if Pa < 0.5 then the compound is unlikely to show signs of the activity but need to be confirmed experimentally [35] .
Docking Studies of MCT with HCC Inducing Factors
Molecular docking predicts the best interaction of proteinligand complexes virtually and determines the appropriate orientation of the inhibitor when bound to a protein [36] . The crystal structure of p53 tumor suppressor protein PDB_ID: 1TSR_B with resolution 2.20Å; crystal structure Hepatocytes Growth Factor PDB_ID: 3HN4_A with resolution of 2.60Å and the crystal structure of TREM1 PDB_ID: 1Q8M_A with resolution of 2.60Å are retrieved from protein data bank. The 3D coordinates of MCT (CID_9415) are retrieved from Pubchem database and prepared for docking with proteins to estimate the binding affinity. The MCT is assigned CHARMM force fields and subjected to energy minimization using the Smart minimizer method implemented in Discovery studio 2.5. This performs 1000 steps of steepest descent with a root mean square gradient tolerance of 3 followed by conjugate gradient minimization until a root mean square deviation (RMSD) of 0.001 kcal/Mol was achieved. The minimized MCT is docked into the active site of the prepared proteins using the GOLD 5.0.1 (Genetic Optimization of Ligand Docking) software. GOLD calculates the docking modes of small molecules in protein binding sites and predicts GOLD score [37] [38] [39] . For each of the ten independent GA runs, maximum number of 100,000 GA operations were performed on a set of five groups with a population size of 100 individuals. The default distance annealing cutoff values of 2.5Å (dH-X) for hydrogen bonds and 4.0Å for Van der Waals interactions are employed. The good conformations of each ligand are selected and analyzed using HERMES to understand the mode of protein-MCT bindings.
In vitro and in vivo Cytotoxic Studies of MCT
Literature mining revealed that very few reports are presented on in vitro and in vivo toxic studies of MCT. Therefore, in vitro tetrazolium salt dye -XTT reagent based cell viability assay (XTT assay), Neutral red dye uptake based cell viability assay (NRU assay), DNA laddering assay for genotoxicity and in vivo brine shrimp assay studies for acute toxicity would provide insight and better understanding of the toxicity of MCT.
Cell Culture and Maintenance
The cell lines like balb/c 3T3 mouse normal fibroblasts and HepG2 cell line (liver cancer cells) are procured from National Centre for Cell Science, India and are maintained for one year. The cell lines are cultured in Dulbecca's Modified Eagle's Medium with 2 mM L-glutamine and Earle's BSS which was adjusted to contain 1.5 g/L sodium bicarbonate, 0.1 mM of the non-essential amino acids, 90% of 1.0 mM sodium pyruvate and 10% fetal calf serum (Sigma-Aldrich), 1% streptomycin and penicillin (Sigma-Aldrich) at 37°C in 95% of humidified atmosphere of 5% CO 2 . The medium was changed twice a week.
XTT Assay
XTT assay is based on the activity of mitochondrial enzymes, which are inactivated shortly after cell death [40, 41] . In brief, trypsinized hepatoma cells from HepG2 cell line from T-25 flask are seeded in 96-well flat-bottomed tissue culture plate at a density of 5x10 3 cells/well in growth medium at 37°C in 5% CO 2 and allowed to adhere. After 24 hrs of incubation, the supernatant was discarded and the cells are pretreated with growth medium, and subsequently mixed with different concentrations of MCT (3.125, 6.25, 12.5, 25, 50, 100, 200 µg/mL according to OECD test guidelines) in triplicates to achieve a final volume of 100 µL and incubated for 48 hrs. Culture medium and DMSO are used as controls. Each well then received 50 µL of fresh XTT reagent (0.9 mg/mL in RPMI along with orange colored tetrazolium salt dye 2,3-Bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazplium-5-carboxyanilide and activator reagent) followed by incubation for 2 hrs at 37°C. At the end of the incubation the 96-well tissue culture plate was shaken for 15 sec and OD of the culture plate was read at 490nm wavelength on Anthos 2020 ELISA reader and the experiment was repeated three times in space and time. The images of cell line before and after treatment are captured using AmScope MU1000 microscope and experiment was repeated three times in space and time at 40X and image was processed with image capture software.
Formulas for Calculation
Where: AB = Absorbance of Blank, AC= Absorbance of Control, AT = Absorbance of Test, CS = percentage of cell survival, CI = percentage of cell inhibition.
DNA Laddering Assay
DNA fragmentation is a semi quantitative method for determining genotoxicity inducing apoptosis in cells [42] . The HepG2 cells are treated with various concentrations of MCT (25, 50 , 100 and 200 µg/mL) and incubated for 48 hrs. The culture medium was discarded from tissue culture flask and the cells are trypsinized with 0.25% of trypsin -EDTA. The Cell suspension was collected in 15 mL centrifuge tube and centrifuged at 3000×g for 5 min. The cells are then lysed with a hypotonic lysis buffer (10 mM Tris-HCl, pH 8.0) containing EDTA (5 mM) and Triton X-100 (0.2%) and then pooled with pellets made of detached cells. RNA was digested using RNase (0.1 mg/mL at 37 °C for 1 hrs) followed by proteinase K treatment for 2 hrs at 50°C. Later the DNA was extracted with a mixture of phenol and chloroform. The DNA was precipitated by adding an equal volume of ice cold isopropyl alcohol, stored overnight at 20°C and centrifuged at 12,000 × g for 15min at 4°C. The pellet was air-dried, resuspended in 20 µL tris acetate EDTA buffer supplemented with 2 µL of sample buffer (0.25% bromphenol blue, 30% glyceric acid) and separated electrophoretically on 2% agarose gel containing 1 µg/mL ethidium bromide and visualized under ultraviolet transilluminator.
NRU Assay
The NRU assay was employed to determine the cytotoxicity and dose-response effect of MCT (Sigma-Aldrich analytical standard >99.0% TLC) on normal mammalian cells (balb/c 3T3 mouse fibroblasts). NRU explicates the viable cells in cultures treated with therapeutic agents [43, 44] . Trypsinized mouse fibroblast cells from balb/c 3T3 mouse fibroblast cell lines are taken from T-25 flask and seeded in 96-well flat-bottomed tissue culture plate at a density of 2 x10 3 cells/well in growth medium and cultured at 37°C in 5% CO 2 to adhere. After 48 hrs of incubation, the supernatant was discarded and the cells are pretreated with growth medium and are subsequently mixed with different concentrations of MCT (3.125, 6.25, 12.5, 25, 50, 100, 200 and 400 µg/mL according to the OECD test guidelines) in triplicates to achieve a final volume of 100 µL and then cultured for 48 hrs [45] . Each well, except blank received 100 µL of freshly prepared neutral red medium (33 µg/mL in MEM) followed by incubation for 3 hrs at 37°C. At the end of the incubation all the solutions in the well are discarded and 200 µL of fixative was added to each well to fix the cells. The solution was removed and replaced with 100 µL of extraction solution in each well, after which the plates are placed at room temperature for 20 min. Plates are shaken with a microplate mixer for 30 seconds and the optical density (OD) of the culture was observed at a wavelength of 540nm on an Anthos, 2020 ELISA reader and the experiment was repeated three times in space and time. The cell viability fraction was calculated as
Acute Toxicity test of MCT on Brine Shrimp (Nauplii)
The Brine shrimp assay is an express test for screening toxicity of active natural products with cytotoxic anti-tumor properties. The Brine shrimp assay is an affordable and viable alternative to mouse bioassay with ethical constraints [46, 47] . Brine shrimp (Artemia salina) eggs are collected from hatcheries and left under constant aeration for 48 hrs in a conical shaped flask (1L) filled with sterile artificial sea water to hatch. After the hatching of eggs, the active nauplii free from the egg shells and are collected from a brighter portion of the hatching chamber and used for the assay. Ten nauplii are drawn through a glass capillary and placed in each vial containing 9 mL of the brine solution. In each experiment, 1 mL of the MCT was added to 9 mL of brine solution and maintained at room temperature for 24 hrs under the light and surviving larvae are counted to calculate LC 50 of the compound. The experiments are conducted along with control (vehicle treated) at different increasing concentrations from 3.125 -2000 µg/mL of MCT in a set of three petri plates per dose and repeated thrice in space and time. The percent of mortality (LC 50 ) was determined using the formula.
Where:
M is the mortality of individuals in time t (%) N is the average number of dead individuals N0 is the initial number of living individuals set in individual concentration
Statistical Analysis
The data generated for triplicates of XTT, NRU and brine shrimp assays of three different individual experiments in space and time are expressed in mean ± SE using SPSS v17.0. The differences between the treatments of HepG2 cells with MCT and 5'-Fluorouracil are observed using t-test.
RESULTS AND DISCUSSIONS
In Silico Predictive Studies of MCT In Silico Predictive Druglikeness of MCT
In silico predictive methods are prompt and cost efficient alternatives for bioassay's to exhume the noxious properties of the compounds during the early phases of drug development. This helps in eliminating compounds with undesired properties and associated health hazards in humans [48, OECD 2004b [48, OECD , 2007b [48, OECD , 2010 . The drug-like properties and physio-chemical parameters of MCT are predicted using QikProp3.5 and LAZARv3a are shown in Table. 1. These results demonstrate that MCT is a drug-like compound with biodegradability. In silico mutagenicity studies predicted MCT as non-mutagenic on Ames mutagen city, KB-Salmonella mutagencity, Deep Brain Stimulation (DBS) mutagenicity. In silico carcinogenicity studies predicted MCT as non-carcinogenic in Male mouse, DBS hamster, DBS rat, DBS mouse and DBS single cell call. The Benigni/Bossa rule based prediction also showed that MCT noncarcinogen. MCT is predicted as a carcinogen on mouse female, rat female, rodent and ISSCAN. However, the majority of the results have exposed MCT as non-carcinogen due to the resistance developed by detoxification in associated with enzymes like glutathione-S-transferase and epoxide hydrolase to detoxify [25] . Hence, MCT is a non-mutagenic and non-carcinogenic compound.
Metabolism and Degradation Pathway of MCT
The toxic PAs, are generally metabolized by the cytochrome P450 (CYP) system, resulting active dehydro alkaloids and pyrroles in liver [52] . SMARTCypv2.4.2 provides the clues for sites of metabolism (SOM) of drug-like compound by the CYP isoforms (cytochrome P450 cascade) accurately up to 86% [32] . SMARTCyp has predicted three SOMs within the pyrrolizidine core ring of MCT. The predicted SOMs are ranked based on the observed scores as shown in Table 2 . The best site of metabolism is assigned to the lowest rank to C13 atoms of MCT with the lowest score followed by C10 atom and C8 atom. The sites of energies with 999 are not considered as site of metabolism as there is no matching energy rule. The results prove that MCT may be effectively metabolized and detoxified by CYP class of enzymes like CYP3A4, CYP2C and CYP2D6 isoforms.
MCT degradation predicted four biotransformation rules (bt0001, bt0002, bt0024 and bt0063) using UM-PPS of microbial degradation as shown in Table 3 . The cleavage products predicted by biotransformation of MCT are carboxylates, aldehydes, ketones and esters which are not toxic. Similar biotransformation of MCT was predicted using UM-PPS to assess the detoxification of MCT Table1.
Predicted drug like properties of MCT using QikProp3.5 and LAZAR. Table 3 showing the UM-PPS predicted biotransformation of MCT at 8 different levels.
in silico [24] . Biotransformation may be the possible mechanism that is adopted by ruminal microbes to metabolize MCT [53] . The resistance developed in animals to MCT is due to the detoxification of esters in pyrrolizidine alkaloids by esterases in the liver, which generates necic acids and free necines that are non-toxic and are excreted renally [54] . From the above results it is evident that MCT undergoes metabolism by CYP3A4 enzyme.
Biological Activity Spectra Prediction of MCT
PASS predicted biological activity spectra of MCT divulged 154 active biological properties against many drug targets as shown in Table 4 . From the high and low 'Pa' values of MCT 23 antineoplastic activities for different cancers were observed and this illustrates MCT's potent drug-like nature. This study has elevated novel potent antineoplastic activity of MCT with 'Pa' of 0.218 against liver cancer. The novel activities of MCT are to be confirmed experimentally to prove superior therapeutic efficacy of MCT as a novel scaffold.
Docking Studies of MCT with HCC Inducing Factors
The docking results show that MCT with p53 protein involved in switching on the oncogenes or turning off the tumor suppressor genes (PDB_ID: 1TSR.B) is showing promising interactions as shown in Fig. 1 . MCT is docked into the core domain of the Table 4 showing the PASS predicted antineoplastic properties of MCT against against major cancers. sequence specific DNA binding activity of p53 protein and forms hydrogen bonding with Arg248, Arg249, Arg273 and a GOLD score of 37.63 is observed and these residues are believed to be present in between 102 -292 which is the core domain reported for possible mutation [9] . The docking results reveal that MCT can efficiently inhibit p53, which is the major gene involved in human liver cancer. Hepatocyte Growth Factor (HGF) plays a major role in metastasis and tumor migration of liver tumors in humans. HGF protein has oncogenic potential in causing HCC observed from the molecular details of HepG2 cell line [13] . The docking results indicate that MCT is docked into the active site of HGF (PDB_ID: 3HN4) and shows potential interactions. The residue Asn88, Asp90 and Lys104 residues of HGF form hydrogen bonds with MCT as shown in Fig. 2 and a GOLD score of 39.51 was observed. From the docking results it was evident that MCT can inhibit the HGF.
HCC is inflammation-linked carcinoma and expression of Triggering Receptor Expressed on Myeloid Cell-1 (TREM1) aids in the progression of liver cancer [15] . The docking of MCT into the active site of TREM-1 (PDB_ID: 1Q8M) showed promising interaction which confirms that MCT can be an effective drug candidate for inhibiting inflammation mediated HCC. As shown in Fig. 3 the residues Gln56, Pro64, Thr66 and Tyr116 are interacting with MCT with an observed GOLD score of 32.02. Overall docking results support the experimental results that MCT is an effective and promising drug-like compound for treating the HCC in humans.
The overall in silico predictive studies are found to be promising to consider MCT as an effective and promising drug-like compound for treating the HCC in humans. This was further supported by in vitro and in vivo experimental studies.
In vitro and in vivo Cytotoxic Studies of MCT
XTT Assay
Antineoplastic activity of MCT was tested on Hepatocellular carcinoma (HCC) based on the results observed from in silico tool PASS. HepG2 is a human hepatocellular carcinoma cell line which is a suitable in vitro replica for studying liver diseases [16] . In vitro cytotoxicity of MCT was assessed by XTT assay against HepG2 cells after exposure to various concentrations of MCT for 48 hrs. The observed O.D values are represented in mean±SE of three individual experiments repeated in space and time. The results indicate that the proliferation rate of hepatoma cells was efficiently inhibited by the antineoplastic effect of MCT as shown in Fig. 4 . At half maximal concentrations of 24.966 µg/mL (IC 50 ) MCT as a single agent was able to inhibit 50% of the HepG2 cells effectively by suppressing the cancer cell proliferation. The observed IC 50 of MCT was, according to stringent endpoint criteria of IC 50 values (below 25 µL for pure compounds) prescribed by American type culture collection [55] . Further, an increase in the concentration showed that 80% of HepG2 cell inhibition at IC 50 200 µg/mL. The activity of the MCT was compared to standard 5'-Fluorouracil against HepG2 cell proliferation which was observed at IC 50 12.5 µg/mL. Significant differences are observed (up to 10-15%) in the inhibition of cells between MCT and 5'-Fluorouracil treatments (t value=0.08).
The untreated HepG2 cell line was taken as control showing malignant hepatocytes. Clusters of cells with enlarged nuclei with increased nucleo-cytoplasmic ratio forming acne are observed in the untreated cells. After treatment, the hepatocytes are shrunk, scattered and degenerated. The treated cells at 25 µg/mL of MCT are remarkably different from the untreated cells of HepG2 cell lines as shown in Fig. 5 . The antiproliferative activity of MCT was confirmed by this assay on HepG2 cells and consequently this study emphasizes the role of MCT as an important drug-like molecule against hepatic carcinoma.
DNA Laddering Assay
The effect of MCT induced apoptosis against HepG2 showed high cytotoxic and apoptotic rates as shown in Fig. 6 . Similarly Machana et al., also have evaluated the genotoxic effect of plant products using DNA laddering assay to assess the genotoxicity and apoptotic effects against human HCC [56] . The results demonstrate that the DNA ladders are indicative of apoptosis, which are evidently observed along with 1500bp DNA markers (M). In the lane (C) untreated HepG2 DNA was loaded. The lanes L1, L2, L3 and L4 are loaded with DNA extract of HepG2 cells treated with various concentrations 25, 50, 100 and 200 µg/mL of MCT for 48 hrs. The distinctive apoptotic DNA damage was not observed at lower concentrations of MCT as shown in Lane L1 in Fig. 6 . Genotoxicity was induced by MCT at higher concentration in HepG2 cells. The Lane, L1 showed no significant DNA damage due to apoptosis, lane L2 showed early stages of apoptosis with mild DNA damage. This result supports that MCT affects the DNA of HepG2 HCC cancer cell DNA at 2 X IC 50 observed in XTT assay. At this concentration MCT might have induced apoptosis. Further, severe DNA damage was observed in lanes L3 and L4 as streaked bands between 100bp to 400bp are indicating apoptosis. The severe DNA damage might have caused death of cancer cells. These results confirm MCT as a robust anticancer agent.
Neutral Red Uptake Assay
NRU assay is the first-level of evaluation to study the in vitro cytotoxic effect of drug-like compounds on normal cells [57] . In general, the toxic compounds alter the cell wall, lysosomal membrane and causes fragility within the lysosomes. These changes are undesirable and irreversible to the cell which leads to inhibition of the cell growth followed by cell death. Thus, depending on the uptake of neutral red dye we can possibly distinguish the dead, viable and damaged cells within a culture. The percentage decrease in the uptake of neutral red dye in MCT treated cell culture was used to determine the relative cytotoxicity. The observed O.D values of three independent experiments in space and time are represented as mean±SE. The percentage of reduction in viable cells was insignificant in dose dependent manner at lower concentrations. The uptake of neutral red dye by the cells after exposing to MCT was shown as a dose response curve in Fig. 7 . The results illustrate that the MCT was not affecting the normal cells at lower concentrations. The IC 50 for MCT observed to affect the normal cells at 264.305 µg/mL. The effects of increasing concentrations of MCT are suggesting a dose-dependent therapeutic efficacy of MCT. This in vitro NRU study promotes MCT as a potential drug candidate due to the minimal adverse effect to the normal cells. 
Acute Toxicity Test of MCT on Brine Shrimp (Nauplii)
The assessment of toxic action of MCT was a pre-requisite to consider MCT as a safe drug. Brine shrimp (Artemia salina) acute lethality assay in most cases correlates with cytotoxicity of natural products [46, 47] . The standard drug Vincristine sulphate showed high mortality rates at LC 50 of 28.061 µg/mL and is believed to be affecting the organism to a greater extent. Significant lethality of nauplii was observed at LC 50 of 1600 µg/mL as shown in Fig. 8 . In general, LC 50 between 500-1000 µg/mL is considered to be exhibiting weak cytotoxic nature and LC 50 greater than 1000 µg/mL are considered to be non-toxic for natural compounds [58] . Treating brine shrimp nauplii with increasing concentrations of MCT resulted in 0% mortality at concentrations up to 200 µg/mL. The observed LC 50 values indicate that MCT affects the organism only at higher concentrations. Similar observations are reported that MCT do not develop any clinical signs of toxicity at lower concentrations and affects the organism only at higher concentrations [59, 20] . This study was a positive sign to proceed further for monitoring biological activities of MCT. 
CONCLUSION
In silico predictive studies are rapid alternatives for bioassays in early phases of drug development. MCT was predicted to be a potential drug candidate against liver cancer because of the antineoplastic activity and impending druglike properties with biodegradability. MCT as a single agent, was able to inhibit the proliferation of HepG2 cells. The in vitro studies of MCT against HCC was proven to be cytotoxic against HepG2 cells using XTT assay at IC 50 value of 24.966 µg/mL and genotoxicity at 2 X IC 50. Therefore, MCT can be a novel scaffold for treating HCC and also may induce lesser adverse events as MCT is not cytotoxic to normal cells up to a concentration of 264.305 µg/mL due to its non-mutagenic and non-carcinogenic nature. Hence, from the observed in silico and in vitro results we conclude that MCT can be a credible druglike compound for treating HCC with superior efficacy and lesser side effects. Further studies of tagging MCT to magnetic nanoparticle are in progress affirming for improved effectiveness against HCC using targeted therapies in treating cancers.
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